A Model-Strengthened Imaging Biomarker for Survival Prediction in EGFR-Mutated Non-small-cell Lung Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Crossref DOI link: https://doi.org/10.1007/s11538-021-00902-7
Published Online: 2021-05-08
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Collin, Annabelle
Groza, Vladimir
Missenard, Louise
Chomy, François
Colin, Thierry
Palussière, Jean
Saut, Olivier https://orcid.org/0000-0002-4130-150X
Text and Data Mining valid from 2021-05-08
Version of Record valid from 2021-05-08
Article History
Received: 19 November 2020
Accepted: 19 April 2021
First Online: 8 May 2021